Transplant Can Be an Option for Patients With Active, Relapsed or Refractory Acute Myeloid Leukemia

Learn More About the Sierra Trial

The SIERRA trial may enable bone marrow transplant even if your AML is not in remission

Learn More About the Sierra Trial

Targeting Acute Myeloid Leukemia

The SIERRA Trial is investigating the use of Iomab-B in patients age 55 and older with active, relapsed or refractory Acute Myeloid Leukemia (AML)

Learn More About SIERRA Trial

What Is It?

Learn More About Iomab-B

Iomab-B is an investigational drug that targets bone marrow and cancer (leukemia) cells. It is used to help patients get ready for bone marrow transplant (BMT)

Learn More